Corrigendum: Remdesivir (GS-5734) Impedes Enterovirus Replication Through Viral RNA Synthesis Inhibition (Front. Microbiol, (2020), 11, (1105), 10.3389/fmicb.2020.01105);Remdesivir (GS-5734) Impedes Enterovirus Replication Through Viral RNA Synthesis Inhibition

Frontiers in Microbiology

Volumn 11, Issue , 2020, Pages

  Ye, Wei ^a   Yao, Min ^a   Dong, Yangchao ^a   Ye, Chuantao ^b   Wang, Dan ^c   Liu, He ^a   Ma, Hongwei ^a   Zhang, Hui ^a   Qi, Libin ^a   Yang, Yuewu ^a   Wang, Yuan ^a   Zhang, Liang ^a   Cheng, Linfeng ^a   Lv, Xin ^a   Xu, Zhikai ^a   Lei, Yingfeng ^a   Zhang, Fanglin ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c XI'AN MEDICAL UNIVERSITY   (China)

Author keywords

antivirals; cRNA; enterovirus; EV71; Remdesivir (GS 5734); vRNA

Indexed keywords

MESSENGER RNA; NUCLEOPROTEIN; REMDESIVIR; RNA DIRECTED RNA POLYMERASE; VIRUS DNA;

AMINO ACID SEQUENCE; ANTIVIRAL ACTIVITY; ANTIVIRAL THERAPY; ARTICLE; BIOINFORMATICS; CELL VIABILITY; CONTROLLED STUDY; COPY NUMBER VARIATION; CYTOTOXICITY ASSAY; EC50; ENTEROVIRUS A71; FLUORESCENCE MICROSCOPY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; MRNA EXPRESSION LEVEL; NONHUMAN; PHYLOGENY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REAL TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA SYNTHESIS; RNA VIRUS; VIRUS ENTRY; VIRUS REPLICATION; VIRUS TITRATION; VIRUS TRANSMISSION; WESTERN BLOTTING;

EID: 85087173331     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2020.621197     Document Type: Erratum

References (30)

1. Agostini M. L., Andres E. L., Sims A. C., Graham R. L., Sheahan T. P., Lu X., et al. (2018). Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. mBio 9:e00221-18. 10.1128/mBio.00221-18 29511076
2. Brown A. J., Won J. J., Graham R. L., Dinnon K. H., Sims A. C., Feng J. Y., et al. (2019). Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase. Antivir. Res. 169:104541. 10.1016/j.antiviral.2019.104541 31233808
3. Bruenn J. A., (2003). A structural and primary sequence comparison of the viral RNA-dependent RNA polymerases. Nucleic Acids Res. 31 1821–1829. 10.1093/nar/gkg277 12654997
4. Chang H. W., Lin Y. W., Ho H. M., Lin M. H., Liu C. C., Shao H. Y., et al. (2013). Protective efficacy of VP1-specific neutralizing antibody associated with a reduction of viral load and pro-inflammatory cytokines in human SCARB2-transgenic mice. PLoS One 8:e69858. 10.1371/journal.pone.0069858 23936115
5. Chang J., Li J., Liu X., Liu G., Yang J., Wei W., et al. (2015). Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn mice. BMC Microbiol. 15:139. 10.1186/s12866-015-0474-9 26169371
6. Cho A., Zhang L., Xu J., Babusis D., Butler T., Lee R., et al. (2012). Synthesis and characterization of 2’-C-Me branched C-nucleosides as HCV polymerase inhibitors. Bioorgan. Med. Chem. Lett. 22 4127–4132. 10.1016/j.bmcl.2012.04.065 22578461
7. Deng J. X., Nie X. J., Lei Y. F., Ma C. F., Xu D. L., Li B., et al. (2012). The highly conserved 5’ untranslated region as an effective target towards the inhibition of Enterovirus 71 replication by unmodified and appropriate 2’-modified siRNAs. J. Biomed. Sci. 19:73. 10.1186/1423-0127-19-73 22889374
8. Fujii K., Nagata N., Sato Y., Ong K. C., Wong K. T., Yamayoshi S., et al. (2013). Transgenic mouse model for the study of enterovirus 71 neuropathogenesis. Proc. Natl. Acad. Sci. U.S.A. 110 14753–14758. 10.1073/pnas.1217563110 23959904
9. Holshue M. L., DeBolt C., Lindquist S., Lofy K. H., Wiesman J., Bruce H., et al. (2020). First Case of 2019 Novel Coronavirus in the United States. N. Engl. J. Med. 382 929–936. 10.1056/NEJMoa2001191 32004427
10. Jacobs M., Rodger A., Bell D. J., Bhagani S., Cropley I., Filipe A., et al. (2016). Late Ebola virus relapse causing meningoencephalitis: a case report. Lancet 388 498–503. 10.1016/S0140-6736(16)30386-5
11. Jordan P. C., Liu C., Raynaud P., Lo M. K., Spiropoulou C. F., Symons J. A., et al. (2018). Initiation, extension, and termination of RNA synthesis by a paramyxovirus polymerase. PLoS Pathog. 14:e1006889. 10.1371/journal.ppat.1006889 29425244
12. Kawakami E., Watanabe T., Fujii K., Goto H., Watanabe S., Noda T., et al. (2011). Strand-specific real-time RT-PCR for distinguishing influenza vRNA, cRNA, and mRNA. J. Virol. Methods 173 1–6. 10.1016/j.jviromet.2010.12.014 21185869
13. Kumar S., Stecher G., Li M., Knyaz C., Tamura K., (2018). MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol. Biol. Evol. 35 1547–1549. 10.1093/molbev/msy096 29722887
14. Lee K. Y., (2016). Enterovirus 71 infection and neurological complications. Korean J. Ped. 59 395–401. 10.3345/kjp.2016.59.10.395 27826325
15. Lee Y. R., Wang P. S., Wang J. R., Liu H. S., (2014). Enterovirus 71-induced autophagy increases viral replication and pathogenesis in a suckling mouse model. J. Biomed. Sci. 21:80. 10.1186/s12929-014-0080-4 25139436
16. Liu J., Dong W., Quan X., Ma C., Qin C., Zhang L., (2012). Transgenic expression of human P-selectin glycoprotein ligand-1 is not sufficient for enterovirus 71 infection in mice. Arch. Virol. 157 539–543. 10.1007/s00705-011-1198-2 22187102
17. Lo M. K., Feldmann F., Gary J. M., Jordan R., Bannister R., Cronin J., et al. (2019). Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge. Sci. Trans. Med. 11:eaau9242. 10.1126/scitranslmed.aau9242 31142680
18. Lo M. K., Jordan R., Arvey A., Sudhamsu J., Shrivastava-Ranjan P., Hotard A. L., et al. (2017). GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses. Sci. Rep. 7:43395. 10.1038/srep43395 28262699
19. Peersen O. B., (2017). Picornaviral polymerase structure, function, and fidelity modulation. Virus Res. 234 4–20. 10.1016/j.virusres.2017.01.026 28163093
20. Saitou N., Nei M., (1987). The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4 406–425. 10.1016/j.ympev.2008.01.019 18343690
21. Schmidt N. J., Lennette E. H., Ho H. H., (1974). An apparently new enterovirus isolated from patients with disease of the central nervous system. J. Infect. Dis. 129 304–309. 10.1093/infdis/129.3.304 4361245
22. Sheahan T. P., Sims A. C., Graham R. L., Menachery V. D., Gralinski L. E., Case J. B., et al. (2017). Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci. Trans. Med. 9:eaal3653. 10.1126/scitranslmed.aal3653 28659436
23. Shu B., Gong P., (2016). Structural basis of viral RNA-dependent RNA polymerase catalysis and translocation. Proc. Natl. Acad. Sci. U.S.A. 113 E4005–E4014. 10.1073/pnas.1602591113 27339134
24. Tchesnokov E. P., Feng J. Y., Porter D. P., Götte M., (2019). Mechanism of inhibition of ebola virus RNA-dependent RNA polymerase by remdesivir. Viruses 11:E326. 10.3390/v11040326 30987343
25. Wang K., Ma H., Liu H., Ye W., Li Z., Cheng L., et al. (2019). The glycoprotein and nucleocapsid protein of hantaviruses manipulate autophagy flux to restrain host innate immune responses. Cell Rep. 27 2075–2091.e5. 10.1016/j.celrep.2019.04.061 31091447
26. Wang M., Cao R., Zhang L., Yang X., Liu J., Xu M., et al. (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 30 269–271. 10.1038/s41422-020-0282-0 32020029
27. Wang W., Duo J., Liu J., Ma C., Zhang L., Wei Q., et al. (2011). A mouse muscle-adapted enterovirus 71 strain with increased virulence in mice. Microb. Infect. 13 862–870. 10.1016/j.micinf.2011.04.004 21612764
28. Warren T. K., Jordan R., Lo M. K., Ray A. S., Mackman R. L., Soloveva V., et al. (2016). Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature 531:381. 10.1038/nature17180 26934220
29. Ye C., Wang D., Liu H., Ma H., Dong Y., Yao M., et al. (2019). An improved enzyme-linked focus formation assay revealed baloxavir acid as a potential antiviral therapeutic against hantavirus infection. Front. Pharmacol. 10:1203. 10.3389/fphar.2020.00201 32180732
30. Ye W., Xu Y., Wang Y., Dong Y., Xi Q., Cao M., et al. (2015). Hantaan virus can infect human keratinocytes and activate an interferon response through the nuclear translocation of IRF-3. Infect. Genet. Evol. 29 146–155. 10.1016/j.meegid.2014.11.009 25461845